- Report
- December 2023
- 52 Pages
Global
From €4318EUR$4,950USD£3,760GBP
- Report
- December 2022
- 68 Pages
Global
- Report
- June 2022
- 55 Pages
Global
From €4318EUR$4,950USD£3,760GBP
- Report
- September 2019
- 119 Pages
Global
From €4318EUR$4,950USD£3,760GBP
- Report
- September 2018
- 15 Pages
Global
- Report
- January 2023
- 295 Pages
Global
From €3489EUR$4,000USD£3,039GBP
- Report
- March 2024
- 200 Pages
Global
From €3620EUR$4,150USD£3,153GBP
- Report
- July 2024
- 339 Pages
Global
From €4361EUR$5,000USD£3,798GBP
- Report
- June 2023
- 340 Pages
Global
From €4361EUR$5,000USD£3,798GBP
- Report
- February 2021
Global
From €3882EUR$4,450USD£3,381GBP
- Report
- September 2024
- 323 Pages
Global
From €4361EUR$5,000USD£3,798GBP
- Report
- July 2024
- 100 Pages
Global
From €3271EUR$3,750USD£2,849GBP
- Report
- February 2024
- 187 Pages
Global
From €3925EUR$4,500USD£3,419GBP
- Report
- November 2023
- 190 Pages
Global
From €3925EUR$4,500USD£3,419GBP
- Report
- July 2024
- 150 Pages
Global
From €3271EUR$3,750USD£2,849GBP
- Report
- January 2025
- 175 Pages
Global
From €3917EUR$4,490USD£3,411GBP
- Report
- October 2023
- 183 Pages
Global
From €3925EUR$4,500USD£3,419GBP
- Report
- February 2024
- 147 Pages
Global
From €4143EUR$4,750USD£3,609GBP
- Report
- February 2024
- 120 Pages
Global
From €4143EUR$4,750USD£3,609GBP
- Report
- April 2023
- 110 Pages
Global
From €4143EUR$4,750USD£3,609GBP

The Drug Discovery AI market is a rapidly growing sector of the pharmaceutical industry, focused on the development of artificial intelligence (AI) technologies to aid in the discovery of new drugs. AI-driven drug discovery is a process that uses machine learning algorithms to identify potential drug targets and develop new drug candidates. AI-driven drug discovery can reduce the time and cost of drug development, as well as improve the accuracy of drug discovery.
The Drug Discovery AI market is composed of a variety of companies, ranging from large pharmaceutical companies to small startups. Companies in the market include Atomwise, Exscientia, Insilico Medicine, and Recursion Pharmaceuticals. These companies are developing AI-driven drug discovery technologies to help accelerate the drug discovery process. Show Less Read more